Reprimand to Onxeo S.A. Disclosure of price sens
Post# of 301275
Disclosure of price sensitive information – approval of patent
Nasdaq Copenhagen has reprimanded Onxeo S.A. for not having disclosed information about approval of a patent as soon as possible in accordance with the then applicable Rules for issuers of shares on Nasdaq Copenhagen, rule 3.1.1.
The complete decision is available in Decisions & Statements on the following link:
http://www.nasdaqomx.com/listing/europe/surve...openhagen/
In order to ensure more transparency about the decisions from the exchange, the exchange publish decisions concerning a reprimand or a fine, with the identity of the issuer. This is stated in Rules for issuers of shares on Nasdaq Copenhagen rule 5.
For further information, please contact: Pernille Gram, Surveillance, tel. 33 93 33 66
(0)
(0)